CIK 0001156039 · Large accelerated filer
Elevance Health, Inc.
Sign in to watch- Ticker
- ELV
- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- FY end
- Dec 31
- Incorporated
- IN
- Entity type
- operating
- EIN
- 352145715
- Phone
- 8003311476
- Business address
- 220 VIRGINIA AVENUE, INDIANAPOLIS, IN, 46204
- Former names
- Anthem, Inc., WELLPOINT, INC, WELLPOINT INC, ANTHEM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,230,357
- in 2 filings
Net −$5,230,357. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-24 | Gallina John E EVP & Chief Financial Officer | Sale | −4,100 | $397.91 | $1.6M | 54,320 |
| 2021-05-24 | Gallina John E EVP & Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −5,775 | 0 | ||
| 2021-05-24 | Gallina John E EVP & Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −1,962 | 0 | ||
| 2021-05-24 | Gallina John E EVP & Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −4,038 | 0 | ||
| 2021-05-24 | Gallina John E EVP & Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −19,908 | 0 | ||
| 2021-05-24 | Gallina John E EVP & Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −14,761 | 0 | ||
| 2021-05-21 | Dixon Robert L JR Director | Sale | −590 | $392.87 | $232K | 8,978 |
| 2021-05-20 | HILL JULIE A Director | Sale | −1,308 | $394.00 | $515K | 31,213 |
| 2021-03-22 | Haytaian Peter D EVP & President, Commercial | Option exercise | +15,593 | $146.93 | $2.3M | 59,544 |
| 2021-03-22 | Haytaian Peter D EVP & President, Commercial | Option exercise | +22,500 | $131.80 | $3.0M | 82,044 |
| 2021-03-22 | Haytaian Peter D EVP & President, Commercial | Sale | −300 | $345.59 | $104K | 81,744 |
| 2021-03-22 | Haytaian Peter D EVP & President, Commercial | Sale | −9,387 | $347.44 | $3.3M | 72,357 |
| 2021-03-22 | Haytaian Peter D EVP & President, Commercial | Sale | −12,416 | $348.52 | $4.3M | 59,941 |
| 2021-03-22 | Haytaian Peter D EVP & President, Commercial | Sale | −26,777 | $349.53 | $9.4M | 33,164 |
| 2021-03-22 | Haytaian Peter D EVP & President, Commercial | Sale | −7,891 | $350.21 | $2.8M | 25,273 |
| 2021-03-22 | Haytaian Peter D EVP & President, Commercial | Sale | −400 | $351.32 | $141K | 24,873 |
| 2021-03-22 | Haytaian Peter D EVP & President, Commercial | Sale | −2,329 | $352.84 | $822K | 22,544 |
| 2021-03-22 | Haytaian Peter D EVP & President, Commercial | Option exercise · Employee Stock Option (Right to Buy) | −15,593 | 0 | ||
| 2021-03-22 | Haytaian Peter D EVP & President, Commercial | Option exercise · Employee Stock Option (Right to Buy) | −22,500 | 1,848 | ||
| 2021-03-05 | Penczek Ronald W SVP, Chief Accounting Officer | Sale | −2,068 | $333.94 | $691K | 3,137 |
Page 21 of 26 · 514 trades